Most Recent Articles: Clinical Sarcoma Researchhttps://clinicalsarcomaresearch.biomedcentral.comMost Recent Articles: Clinical Sarcoma ResearchPartial response to erlotinib in a patient with imatinib-refractory sacral chordomahttps://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00149-1Chordoma is a rare, slow growing and locally aggressive mesenchymal neoplasm with uncommon distant metastases. It is a chemo-resistant disease with surgery and radiotherapy being the mainstay in treatment of l...Case ReportSat, 12 Dec 2020 00:00:00 GMThttps://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00149-1Saurav Verma, Surya Prakash Vadlamani, Shamim Ahmed Shamim, Adarsh Barwad, Sameer Rastogi and S. T. Arun Raj2020-12-12T00:00:00ZLocally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy responsehttps://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00150-8Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue tumor that typically affects the lower limbs of men between the ages of 50 and 60. EMC of the shoulder is rare with a high risk of local recurren...Case ReportFri, 11 Dec 2020 00:00:00 GMThttps://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00150-8Luca Improta, Sergio Valeri, Rossana Alloni, Chiara Pagnoni, Francesco Mallozzi Santa Maria, Beniamino Brunetti, Carlo Greco, Irene Aprile, Mirella Maselli, Bruno Vincenzi and Alessandro Gronchi2020-12-11T00:00:00ZThe role of prognostic nutritional index in the management of pulmonary sarcomatoid carcinomahttps://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00148-2Pulmonary sarcomatoid carcinoma is characterized by poor survival rates compared with other non-small cell lung cancer. Prognostic nutritional index has significant prognostic value in many malignant tumors. W...ResearchMon, 07 Dec 2020 00:00:00 GMThttps://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00148-2Yan Wang, Yu Cao and Junfeng Liu2020-12-07T00:00:00ZIfosfamide-induced encephalopathy: the EEG with frontal intermittent delta activity, and rapid resolution with methylene blue: A case reporthttps://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00147-3Encephalopathy is an established side effect of the chemotherapeutic agent, ifosfamide, occurring in 10–30% of cases. The EEG commonly shows non-specific features of encephalopathy, and rarely shows frontal in...Case ReportSat, 28 Nov 2020 00:00:00 GMThttps://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00147-3Juliette E. Hamilton, Michael Alexander and Fergal C. Kelleher2020-11-28T00:00:00ZSimultaneous diagnosis of liver PEComa in a family with known Li–Fraumeni syndrome: a case reporthttps://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00143-7Li–Fraumeni syndrome (LFS) is an autosomal dominant hereditary disease. It is associated with the loss of function of the p53 protein and an increased risk of malignant tumor development at early age. The most...Case ReportTue, 24 Nov 2020 00:00:00 GMThttps://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00143-7María del Mar Galera López, Iván Márquez Rodas, Carolina Agra Pujol, Ángela García Pérez, Enrique Velasco Sánchez and Rosa Álvarez Álvarez2020-11-24T00:00:00Z